Investigational Selective JAK1 Inhibitor Improves Measures of Disease Activity in RA

Article Figures & Data

Figures

  • Figure 1.

    Results of the Efficacy Endpoints

    ACR20=American College of Rheumatology 20% improvement criteria; CRP=C-reactive protein; DAS28=disability activity score in 28 joints; GA=general assessment; HAQ-DI=Health Assessment Questionnaire-Disability Index; SJC=swollen joint count; TJC=tender joint count.Reproduced with permission from FP Vanhoutte, MD.